Social protection has seen a sharp focus in the development policy agenda during the past decade. There is also a clear trend for making social protection, as well as food security, “rights-based”, rather than “discretionary”. Yet, no clear consensus has so far emerged concerning many basic design choices and implementation modalities. The Food Security Act 2011, which is now under the consideration of our parliament, is designed to achieve the...
More »SEARCH RESULT
RURAL URBAN DIVIDE: A TALE OF TWO INDIAS
A government report lends credence to the notion of “two Indias”, or the distinction between “India” and “Bharat” – a theme often debated in recent years. At a time when urban India is growing and policy makers have expressed clear preference for the trend, this report, by National Sample Survey Organisation (NSSO), brings India’s deep urban-rural divide into focus, showing disparities in scale and levels of expenditure and consumption and, equally...
More »Malaria drug, made in India
-The Telegraph An Indian pharmaceutical company has tweaked and tested a synthetic molecule first created in an American university and developed the world's latest drug against malaria, an alternative to standard anti-malarial therapy. India’s Ranbaxy Laboratories today launched the new drug for the treatment of uncomplicated malaria caused by the Plasmodium falciparum parasite, after nine years of research which was partly supported by the Indian government. Clinical trials in India, Tanzania, and Thailand...
More »Western warnings-R Ramachandran
India is coming under increasing pressure from the U.S. and the European Union for the strict patentability criteria it applies for medicines. AS was only to be expected, the two landmark decisions made by the Indian patent office in recent times concerning pharmaceutical patent cases have not gone down well with the multinational drug industry. First, there was the rejection in 2006 of the patent application by the Swiss multinational...
More »Patent to plunder -Amit Sengupta
India's efforts to produce and supply life-saving drugs at affordable prices face challenges from multinational companies trying to “evergreen” their patents. THE average life expectancy across the globe has increased from around 30 years a century ago to over 65 years today. This has been made possible in large part by modern medicine. Never before in history have humans had access to such an array of medicines and devices to...
More »